Here are three stocks offering attractive yields of up to 4.9%, each backed by strong businesses.

Fintel reports that on December 12, 2025, Morgan Stanley maintained coverage of Bristol-Myers Squibb Company - Preferred Security (OTCPK:BMYMP) with a Underweight recommendation. Analyst Price ...

Despite trading near its 52-week low and posting a year-to-date loss of approximately 28%, BioNTech stock is attracting significant attention from major fina ...

The Global Immuno-oncology Clinical Trials Market is expanding steadily due to the rise in cancer incidence, rapid scientific progress in immunotherapy, and growing investments in precision oncology ...